ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/N-Boc-D-tert-leucine
C11H21NO4
231.29 g/mol
Pharmaceutical IntermediateWarning

(2R)-2-{[(tert-butoxy)carbonyl]amino}-3,3-dimethylbutanoic acid

CAS124655-17-0EC676-419-3
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

This compound is a protected amino acid derivative, specifically a tert-butoxycarbonyl (Boc)-protected form of D-tert-butylglycine. It is primarily used as a building block in peptide synthesis, where the protecting groups facilitate controlled formation of peptide bonds.

Building block for solid-phase peptide synthesisIntermediate in the manufacture of custom peptides for research

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

ReferenceSame Category

3-methylazetidin-3-ol Hydrochloride

CAS124668-46-8

pharmaceutical intermediate

ReferenceSame Category

(1S,4R)-4-(2-Amino-6-chloro-9H-purin-9-yl)cyclopent-2-ene-1-carboxylic acid

CAS1246819-78-2

pharmaceutical intermediate

ReferenceSame Category

2-(4-ethylphenyl)-2-methylpropanoic acid

CAS1247119-83-0

pharmaceutical intermediate

ReferenceSame Category

5-(4'-Bromomethyl-1,1'-biphenyl-2-yl)-1-triphenylmethyl-1H-tetrazole

CAS124750-51-2

pharmaceutical intermediate

Referencestereoisomer of

N-Boc-L-tert-Leucine

CAS62965-35-9

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more

Safety Reference

Harmful
Harmful
Warning
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
Identifiers
IUPAC Name

(2R)-3,3-dimethyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid

InChIKey

LRFZIPCTFBPFLX-ZETCQYMHSA-N

SMILES

CC(C)(C)[C@H](C(=O)O)NC(=O)OC(C)(C)C

Synonyms (19)
  • BOC-D-ALPHA-TERT-BUTYLGLYCINE
  • Boc-D-a-tert-butyl-Gly-OH
  • N-Boc-D-tert-butylglycine
  • N-Boc-D-tert-leucine
  • boc-d-tert-leucine
  • boc-d-tle-oh

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→